로딩 중…
지수 로딩 중…
Standard BioTools Inc.
LAB· NASDAQ· Health Care· Health Care Equipment & Services
$0.83+2.42%
2026-06-18
Price Chart
Standard BioTools Inc.-23.88%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $324M |
| Revenue | $66M |
| Net Income | $-94M |
| Total Assets | $639M |
| Net Assets | $561M |
| Value | |
| P/B | 0.58x |
| P/S | 4.93x |
| FCF Yield | -29.17% |
| Profitability | |
| ROE | -16.77% |
| ROA | -14.72% |
| Op. Margin | -103.15% |
| Revenue Growth | -48.17% |
| Financial Health | |
| Debt Ratio | 13.90% |
| Total Debt | $29M |
| FCF | $-94M |
| Cash | $266M |
| Current Ratio | 12.36x |
| Performance | |
| 1Y Return | -23.88% |
| 1M Return | -17.03% |
| From 52W High | -51.76% |
| 1Y MDD | -52.19% |
| Trading | |
| Volume | 3,147,184 shares |
| Trading Value | $3M |
| Per Share | |
| EPS | $-0.19 |
| BPS | $1.10 |